An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease.
Alzheimer's disease (AD) is associated with neuronal degeneration, synaptic loss and deficits in multiple neurotransmitter systems. Alterations in the serotonin 1A (5-HT1A) receptor can contribute to impaired cognitive function in AD, and both in vitro binding and Positron emission tomography (PET) imaging studies have demonstrated that 5-HT1A receptors in the hippocampus/medial temporal cortex are affected early in AD. This neuropathological study examined the localization and immunoreaction intensity of 5-HT1A receptor protein in AD hippocampus with the goal to determine whether neuronal receptor levels are influenced by the severity of NFT severity defined by Braaks' pathological staging and to provide immunohistochemical confirmation of the binding assays and PET imaging studies. Subjects included AD patients and non-AD controls (NC) stratified into three Braaks' stages (Braak 0-II, NC; Braak III/IV and V/VI, AD). In the Braak 0-II group, 5-HT1A-immunoreactivity (ir) was prominent in the neuropil of the CA1 and subiculum, moderate in the dentate gyrus molecular layer (DGml), and low in the CA3 and CA4. No changes in 5-HT1A-ir were observed in the hippocampus of AD subjects in the Braak III/IV group. Hippocampal 5-HT1A-ir intensity was markedly decreased in the CA1 region in 6/11 (54.5%) subjects in the Braak V/VI group. Across all three groups combined, there was a statistically significant association between reduced 5HT1A-ir and neuronal loss in the CA1, but not in the CA3. The present data demonstrate that hippocampal 5-HT1A receptors are mainly preserved until the end-stage of NFT progression in AD. Thus, the utility of PET imaging using a 5-HT1A-specific radiolabeled probe as a marker of hippocampal neuronal loss may be limited to the CA1 field in advanced stage AD cases.
Department of Psychiatry, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan. mizukami@md.tsukuba.ac.jp
Katsuyoshi
K
Mizukami
Masanori
M
Ishikawa
Hiroyasu
H
Akatsu
Eric E
EE
Abrahamson
Milos D
MD
Ikonomovic
Takashi
T
Asada
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000276:immunology / Q000378:metabolism* / Q000473:pathology*; D015415:Biomarkers / Q000737:chemistry / Q000378:metabolism; D005260:Female; D006624:Hippocampus / Q000737:chemistry* / Q000276:immunology / Q000473:pathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017966:Pyramidal Cells / Q000737:chemistry / Q000276:immunology / Q000473:pathology; D044282:Receptor, Serotonin, 5-HT1A / Q000096:biosynthesis* / Q000737:chemistry / Q000172:deficiency
D015415:Biomarkers; D044282:Receptor, Serotonin, 5-HT1A
J Pharmacol Exp Ther. 2005 Sep;314(3):1274-89
15951399
Neurology. 1991 Apr;41(4):479-86
2011243
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):702-7
16407119
Brain Res. 2003 Jun 6;974(1-2):82-7
12742626
J Urol. 2006 Oct;176(4 Pt 1):1648-53
16952708
J Neurol Sci. 1984 May;64(2):109-17
6747659
Behav Brain Res. 2008 Dec 16;195(1):103-11
18606193
Exp Neurol. 1997 Oct;147(2):333-45
9344558
J Neurol Sci. 1991 Nov;106(1):50-5
1779239
Brain Res. 1997 Jan 16;745(1-2):96-108
9037397
Neurology. 1984 Jul;34(7):939-44
6610841
Brain Res. 2003 Mar 28;967(1-2):181-90
12650979
Ann N Y Acad Sci. 1990;600:405-15; discussion 415-7
1701291
J Neurosci Res. 1996 Dec 15;46(6):697-708
8978504
Neuropharmacology. 1984 Dec;23(12B):1561-9
6084823
Neuroimage. 2008 Apr 15;40(3):1251-6
18313943
Acta Neuropathol. 1991;82(4):239-59
1759558
Ann N Y Acad Sci. 1990;600:36-52
2252320
Neuroscience. 1990;39(3):613-27
1965859
Neurology. 2007 Sep 4;69(10):1012-7
17785670
J Neurochem. 1984 Dec;43(6):1574-81
6208336
Brain Res. 1998 Jul 13;799(1):156-8
9666111
Neuropsychopharmacology. 1998 Jun;18(6):407-30
9571651
J Neural Transm (Vienna). 2007 Sep;114(9):1179-85
17308980
J Neurochem. 2005 May;93(4):910-7
15857394
Epilepsy Res. 2001 Nov;47(1-2):127-39
11673027
Brain Res. 2003 Jan 3;959(1):58-67
12480158
Exp Neurol. 1999 Nov;160(1):194-204
10630204
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14731-6
11121072